INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice
Article in Future Oncology (January 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Future Oncology (January 2024)
Article in Current Oncology (November 2023)
Article in Clinical Lymphoma Myeloma & Leukemia (October 2023)